You are here

Article Text

Article menu
Download PDFPDF
Extended reports
Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis
  1. M Fujimotoa,b,
  2. M Shimozumab,
  3. N Yazawaa,
  4. M Kuboa,
  5. H Ihna,
  6. S Satoa,
  7. T Tamakia,
  8. K Kikuchia,
  9. K Tamakia
  1. aDepartment of Dermatology, Faculty of Medicine, University of Tokyo, Japan , bDivision of Dermatology, Kosei General Hospital, Tokyo, Japan
  1. Dr M Fujimoto, Department of Dermatology, Faculty of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113, Japan.

Abstract

OBJECTIVE To determine the prevalence of 52-Kda and 60-Kda Ro/SS-A autoantibodies in serum samples from Japanese patients with systemic sclerosis (SSc).

METHODS Serum samples from 263 Japanese patients with SSc were examined by double immunodiffusion and enzyme linked immunosorbent assay (ELISA).

RESULTS By double immunodiffusion, 29 serum samples from patients with SSc were found to possess anti-Ro/SS-A antibodies. By ELISA, 31 serum samples were positive for anti-Ro52 and/or anti-Ro60. Of 27 serum samples that were positive by both methods, 15 reacted with both Ro52 and Ro60, five with Ro52 alone, and seven with Ro60 alone. Eleven of 12 patients with both anti-Ro52 and anti-Ro60 and all five patients with anti-Ro52 alone had Sjögren’s syndrome, while only one of six patients with anti-Ro60 alone had this disorder.

CONCLUSIONS Anti-Ro52 may be a serological marker for the presence of Sjögren’s syndrome in anti-Ro/SS-A-positive patients with SSc.

  • anti-Ro/SS-A antibodies
  • systemic sclerosis
  • Sjögren’s syndrome

https://doi.org/10.1136/ard.56.11.667

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text